Stocklytics Platform
Asset logo for symbol COLL
Collegium Pharmaceutical
COLL80
$29.78arrow_drop_up0.10%$0.03
High Quality
Asset logo for symbol COLL
COLL80

$29.78

arrow_drop_up0.10%

Performance History

Chart placeholder
Key Stats
Open$29.06
Prev. Close$29.22
EPS2.34
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range26.81
29.88
52 Week Range20.95
42.23
Ratios
EPS2.34

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Collegium Pharmaceutical (COLL)

Collegium Pharmaceutical Inc (COLL) is a biopharmaceutical company that focuses on developing and commercializing innovative products for the treatment of chronic pain. With a history dating back to 2002, Collegium has established itself as a leader in the pain management space. The company's stock price has experienced significant fluctuations over the years, reflecting the challenges and opportunities faced by the pharmaceutical industry.
As of the latest quote, COLL stock is trading at $20.45 per share. This represents a decrease of 2.46% from the previous closing price. Investors are closely watching the stock and monitoring for any news or updates that could impact its value. The company is committed to delivering long-term value to its shareholders, and its management team is focused on executing its growth strategies.
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
CEO
Mr. Joseph J. Ciaffoni
Headquarters
Stoughton
Employees
207
Exchange
NASDAQ
add Collegium Pharmaceutical  to watchlist

Keep an eye on Collegium Pharmaceutical

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Collegium Pharmaceutical 's (COLL) price per share?

The current price per share for Collegium Pharmaceutical (COLL) is $29.78. The stock has seen a price change of $0.03 recently, indicating a 0.1% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Collegium Pharmaceutical (COLL)?

For Collegium Pharmaceutical (COLL), the 52-week high is $42.23, which is 41.81% from the current price. The 52-week low is $20.95, the current price is 42.15% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Collegium Pharmaceutical (COLL) a growth stock?

Collegium Pharmaceutical (COLL) has shown an average price growth of -6.8% over the past three years. It has received a score of 72 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Collegium Pharmaceutical as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Collegium Pharmaceutical (COLL) stock price performance year to date (YTD)?

As of the latest data, Collegium Pharmaceutical (COLL) has a year-to-date price change of -4.64%. Over the past month, the stock has experienced a price change of -18.32%. Over the last three months, the change has been -17.48%. Over the past six months, the figure is -12.8%. Looking at a longer horizon, the five-year price change stands at 56.41%.
help

Is Collegium Pharmaceutical (COLL) a profitable company?

Collegium Pharmaceutical (COLL) has a net income of $48.16M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 57.55% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 35.17% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $566.77M, with a revenue growth rate of 22.17%, providing insight into the company's sales performance and growth. The gross profit is $326.17M. Operating income is noted at $166.96M. Furthermore, the EBITDA is $358.05M.
help

What is the market capitalization of Collegium Pharmaceutical (COLL)?

Collegium Pharmaceutical (COLL) has a market capitalization of $959.44M. The average daily trading volume is 29.78, indicating the stock's liquidity and investor engagement.

News

Take Your Investments to a Whole New Level